OpenVSafe by OpenVAERS
Search V-safe

ZPJ-13396-23247

2 vaccinations 4 coded responses 13 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
921 / CA
Registered
2020-12-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-15
    Registered in v-safe
  2. 2020-12-15
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-15
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2020-12-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2020-12-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2020-12-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-05
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-05
    Survey response — day 21, dose 1
    MedDRA: Myalgia, Nasal congestion — Feeling: Fair
    Free text: Muscle pain, nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-06
    Survey response — 3 months, dose 2
    MedDRA: Thrombophlebitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Superficial thrombophlebitis of RUE
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-06
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-05-18
    Call successful
    Participant prefers to complete VAERS report online
  18. 2022-01-05
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-15Pfizer-BioNTech
22021-01-05Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-04-06 Successful
2021-05-18
Participant prefers to complete VAERS report online

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-20

Systemic reaction (other): Runny nose

2020-12-21

Systemic reaction (other): Sore throat

Release 1 — day 21, dose 1

2021-01-05

Symptoms: Muscle pain, nasal congestion

Release 7 — 3 months, dose 2

2021-04-06

Symptoms: Superficial thrombophlebitis of RUE

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMyalgia ✓ ✓ ✓
SDNasal congestion ✓ ✓ ✓
SDThrombophlebitis ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release